NCT03732859View on ClinicalTrials.gov

PROOF-Registry New and Extended Belgium -Luxembourg

CompletedOBSERVATIONAL
Enrollment

575

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

November 1, 2021

Study Completion Date

January 9, 2022

Conditions
Idiopathic Pulmonary Fibrosis
Trial Locations (9)

1070

Cliniques Universitaires de Bruxelles - Hôpital Erasme, Brussels

1200

Cliniques universitaires Saint-Luc, Brussels

1210

Centre Hospitalier de Luxembourg (CHL)/ Luxembourg Institute of Health (LIH), Luxembourg

2000

Ziekenhuisnetwerk Antwerpen vzw, Antwerp

3000

University Hospitals Leuven, Leuven

4000

Centre Hospitalier Universitaire Sart Tilman, Liège

CHR de la Citadelle, Liège

5530

CHU UCL Namur asbl - site Godinne, Yvoir

9000

Universitair Ziekenhuis Gent, Ghent

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Roche Farma, S.A

INDUSTRY

lead

Belgian Thoracic Society

OTHER

NCT03732859 - PROOF-Registry New and Extended Belgium -Luxembourg | Biotech Hunter | Biotech Hunter